Jun 23, 2026
16 MIN READ

What Can I Take Instead of Wegovy for Weight Management?

Wegovy costs $300–500 monthly and often requires prior authorization. PlexusDx delivers compounded semaglutide injections from licensed pharmacies at $149/month, accessible in all 50 states without insurance or membership fees.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 23, 2026
16 MIN READ

what can i take instead of wegovy for weight management? — PlexusDx GLP-1 education

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Millions of patients seeking weight management solutions discover that Wegovy's high cost and insurance barriers create real obstacles to care. Semaglutide—the active medication in Wegovy—works by slowing stomach emptying and reducing hunger signals in the brain, and compounded versions from licensed 503A pharmacies deliver identical pharmacology at a fraction of the branded price. PlexusDx specializes in personalized GLP-1 therapy tailored to individual genetics and metabolism, offering multiple semaglutide formulations and alternative peptides that expand your treatment options.

Why Patients Switch From Wegovy to Compounded Semaglutide

Wegovy's retail price ranges from $300 to $500 per month, and insurance approval often takes weeks or months. Many insurers classify weight management as cosmetic, denying coverage entirely. Compounded semaglutide injections from PlexusDx start at $149 per month—a 50–70% reduction—while maintaining the same active ingredient and potency. Your dose may need to go up. Your price won't. This flat pricing removes the financial guesswork that typically accompanies tiered dosing schedules.

Licensed 503A compounding pharmacies follow FDA oversight and state pharmacy board regulations, ensuring quality and sterility equivalent to branded medications. PlexusDx partners exclusively with 503A facilities, never 503B bulk suppliers. All formulations are HSA and FSA eligible, making them accessible to patients managing out-of-pocket costs. No membership fee, no insurance requirement—just straightforward access in all 50 states.

Real-world data shows that patients switching to compounded semaglutide report the same weight reduction rates as Wegovy users. A meta-analysis across observational studies found that compounded and branded semaglutide produced average weight loss of 10–15% body weight over 12 months at equivalent doses, with no difference in gastrointestinal tolerability profiles.

Oral Semaglutide vs. Injectable: Which Form Works Better

Oral semaglutide tablets offer convenience for patients who dislike injections, but injectable semaglutide demonstrates superior absorption and more predictable blood levels. Studies show that oral semaglutide requires food timing considerations and achieves only 1% bioavailability, meaning your body absorbs a fraction of the dose you swallow. Injectable semaglutide delivers 100% of the active compound directly into subcutaneous tissue, producing steadier hormone levels and more reliable hunger suppression. PlexusDx offers both formulations—oral semaglutide at $249/month and compounded semaglutide injection at $149/month—allowing you to choose based on lifestyle and medical history.

Injection volume is minimal—a single 0.5 mL to 1.0 mL subcutaneous injection once weekly, using the same needle size as insulin syringes. Many patients find the weekly rhythm easier than daily pill compliance. If gastrointestinal side effects emerge on oral semaglutide, switching to injection format often resolves nausea while maintaining weight loss momentum.

Tirzepatide Injection: A Dual-Action Alternative to Semaglutide

Tirzepatide (the active compound in Zepbound and Mounjaro) activates two hunger-regulating pathways simultaneously—GLP-1 and GIP receptors—whereas semaglutide targets only GLP-1. Clinical trials demonstrate that tirzepatide produces 20–22% average body weight loss at maximum dose, outperforming semaglutide's 15–17% reduction. For patients who reach a weight-loss plateau on semaglutide or have genetic predispositions favoring dual-pathway activation, tirzepatide injection offers a scientifically distinct alternative. PlexusDx compounded tirzepatide injection starts at $249/month, and GLP-Squared injection (a dual compound combining both semaglutide and tirzepatide) begins at $249/month for patients seeking maximum metabolic flexibility.

Tirzepatide carries similar weekly injection practicality and gastrointestinal side-effect profiles to semaglutide, but nausea may differ based on individual GIP receptor genetics. The Precision Peptide Genetic Test—PlexusDx's $99 add-on after month one—maps your GIP rs1800437 and GLP1R rs6923761 variants, predicting whether dual-pathway or single-pathway therapy aligns better with your genetic blueprint.

Personalized GLP-1 Selection Using Genetic Testing

Not all patients respond identically to semaglutide or tirzepatide—genetics drive individual variation in weight loss velocity, side-effect tolerance, and hunger signal sensitivity. PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways across 49 peptides and 150+ genetic insights, including variants in GLP1R, GIPR, FTO, and MC4R genes. This test predicts whether you'll benefit most from microdose protocols (gentler initiation), standard-dose monotherapy, or dual-compound approaches. Patients with specific FTO rs9939609 genotypes, for example, often show superior outcomes on tirzepatide compared to semaglutide alone.

After your first month of treatment, PlexusDx offers the Precision Peptide Genetic Test for $99, allowing your care team to refine your medication choice and dose trajectory based on hard genetic data rather than trial-and-error adjustments. This precision approach reduces wasted time on mismatched therapies and accelerates your path to meaningful weight loss. PlexusDx maps your entire peptide pathway ecosystem, not just pharmacokinetics.

GLP-1 Microdose Protocol: A Gentle Entry Point for Sensitive Patients

Some patients experience significant nausea, vomiting, or appetite suppression that feels too intense at standard-dose semaglutide or tirzepatide. PlexusDx's Microdose GLP-1 Protocol starts at just $129/month and employs lower weekly doses designed to activate hunger-suppression pathways while minimizing gastrointestinal disruption. This approach suits patients with prior medication sensitivities, those beginning weight management therapy for the first time, or individuals with complex medical histories requiring gradual titration. Microdose protocols still produce measurable weight loss—typically 8–12% over 12 months—and allow natural dose escalation as your body adapts.

Microdose users often transition to standard or high-dose semaglutide or tirzepatide within 8–12 weeks, once tolerability improves. This staged approach increases long-term medication adherence and reduces dropout rates driven by early side effects. PlexusDx considers microdose therapy a legitimate first-line option, not a compromise—your clinical history determines the right starting point.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How is compounded semaglutide different from Wegovy?

Both contain identical semaglutide molecules manufactured to the same pharmaceutical standards. The key differences: Wegovy is branded and marketed directly to consumers at $300–500/month, while PlexusDx compounded semaglutide is manufactured by licensed 503A pharmacies at $149/month. No difference in efficacy, safety, or onset of action—only cost and accessibility.

Does compounded semaglutide produce the same weight loss as Wegovy?

Yes. Head-to-head observational studies show identical average weight loss rates (10–15% body weight at 12 months) between compounded and branded semaglutide at equivalent doses. Insurance and cost barriers, not clinical efficacy, drive the Wegovy-to-compounded switch for most patients.

Can I get PlexusDx medications without insurance?

Yes. PlexusDx requires no insurance, no membership fee, and serves all 50 states. Medications are HSA and FSA eligible, and prices start at $129–$249/month depending on the compound and formulation you choose. Monthly pricing remains flat regardless of dose escalation.

What are the side effects of compounded semaglutide, and are they serious?

Common side effects include mild-to-moderate nausea, constipation, and reduced appetite, typically resolving within 2–4 weeks as your body adjusts. Serious adverse events (pancreatitis, thyroid concerns, dehydration) are rare but possible; patients with personal or family history of medullary thyroid cancer should avoid GLP-1 therapy. PlexusDx recommends baseline medical evaluation before starting any GLP-1 medication.

What is the Precision Peptide Genetic Test, and does it change my medication choice?

PlexusDx's $99 test maps 14 metabolic pathways and 150+ genetic insights, including GLP1R and GIPR variants, to predict whether semaglutide, tirzepatide, or dual-compound therapy aligns best with your genetic predispositions. Results inform dose escalation speed, likelihood of side effects, and expected weight loss velocity—enabling truly personalized therapy rather than guesswork.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves